Together these findings suggest that SMM-189 may reduce the pro-inflammatory response by increasing the expression of both endogenous CB2 expression and PKA, thereby inducing signal transduction via the PKA pathway and ultimately suppressing DSS-induced colitis. The gene discussed is CNR2; the disease is colitis.